To begin each module, results of interactive audience polling using networked iPads will be juxtaposed with the findings from a survey comprising case-based and related management questions completed by 25 clinical investigators prior to the meeting. Each faculty member will then deliver a presentation reviewing recently published research data and ongoing clinical trials related to the topics and questions addressed via the surveys. After each presentation, moderated panel discussion will take place to generate other relevant perspectives and dialogue.
MODULE 1: First-Line Systemic Therapy for Patients with Unresectable Hepatocellular Carcinoma (HCC) — Dr Finn
MODULE 2: Available Data with and Patient Selection for Anti-angiogenic Therapy for Progressive Metastatic HCC — Dr Zhu
MODULE 3: Published Data with and Appropriate Integration of Immune Checkpoint Inhibitors into the Care of Patients with Progressive Metastatic HCC — Dr El-Khoueiry
MODULE 4: Novel Approaches Under Investigation for Advanced HCC — Prof Galle
MODULE 5: Current and Future Management of Advanced Biliary Tract Cancers — Dr Abou-Alfa
Target Audience
This activity is intended for medical oncologists, hematology-oncology fellows, surgeons and other healthcare providers involved in the treatment of gastrointestinal cancers.
Learning Objectives
At the conclusion of this activity, participants should be able to:
CME Credit Form
A CME credit form will be given to each participant at the conclusion of the activity.
Accreditation Statement
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
Research To Practice designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Policy
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess conflicts of interest with faculty, planners and managers of CME activities. Conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. Financial disclosures will be provided in meeting course materials.
Supporters
This activity is supported by educational grants from Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb Company, Exelixis Inc, Genentech, Incyte Corporation and Lilly.
InterContinental San Francisco
888 Howard Street
San Francisco, CA 94103
Hotel Phone: (415) 616-6500
Meeting Room
Grand Ballroom (Third Floor)
Directions
The InterContinental San Francisco hotel is adjacent to the Moscone Center, where the 2020 Gastrointestinal Cancers Symposium is taking place.
Thank you for your interest in our CME program. At this time online preregistration is closed for this event. SEATS ARE STILL AVAILABLE FOR THIS SESSION. Our ONSITE REGISTRATION DESK will be open starting at 5:30 PM on Friday January 24th. If you are interested in attending, please visit our registration desk located outside the Grand Ballroom (3rd Floor) of the InterContinental San Francisco hotel (888 Howard Street) near the Moscone Convention Center.
We will accept onsite registrations, with priority given to clinicians in practice, on a first come, first served basis. Please note, onsite registration does not guarantee participation in the session or meal service.
If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com or call (800) 233-6153.
NOTICE:
Registration for this event is independent of registration for the Gastrointestinal Cancers Symposium.